The macrolide revival: Thirty five years after erythromycin
- 1 April 1987
- journal article
- Published by Elsevier in Antimicrobic Newsletter
- Vol. 4 (4) , 25-34
- https://doi.org/10.1016/0738-1751(87)90002-5
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- The renaissance of erythromycinJournal of Antimicrobial Chemotherapy, 1986
- In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzaeAntimicrobial Agents and Chemotherapy, 1986
- Prevalence of antimicrobial resistance among clinical isolates ofHaemophilus influenzaeDiagnostic Microbiology and Infectious Disease, 1986
- Erythromycin Uptake and Accumulation by Human Polymorphonuclear Leukocytes and Efficacy of Erythromycin in Killing Ingested Legionella pneumophilaThe Journal of Infectious Diseases, 1984
- In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1984
- Translational Attenuation: The Regulation of Bacterial Resistance to the Macrolide-Lincosamide-Streptogramin B AntibioticCritical Reviews in Biochemistry, 1984
- MEASUREMENT OF PULMONARY ERYTHROMYCIN CONCENTRATION IN PATIENTS WITH LOBAR PNEUMONIA BY MEANS OF POSITRON TOMOGRAPHYThe Lancet, 1982
- ErythromycinMedical Clinics of North America, 1982
- Sensitivity of Group A Streptococci to AntibioticsAmerican Journal of Diseases of Children, 1979
- Chemical and stereochemical modifications of the erythromycin lactone ringsThe Journal of Organic Chemistry, 1974